About Rodney Rocconi
Dr. Rodney P. Rocconi currently serves as interim director of USA Health Mitchell Cancer Institute and associate director for clinical research. As a professor of gynecologic oncology, he is credited with more than 150 research presentations at national meetings and more than 100 publications. His research interests include genetic contributions of racial health-care disparities in gynecologic malignancies as well as the molecular mechanisms of chemo-resistance in ovarian cancer.
His research program has been supported by multiple NIH/NCI and foundation grants. He has been recognized for his work as a recipient of the Gynecologic Cancer Foundation Ovarian Cancer Research Award, the Gynecologic Oncology Group Young Investigator Research Award and an invited associate member of the NCI Early Detection Research Network. These experiences have allowed him to serve in numerous national leadership roles in the Society of Gynecologic Oncology, the NRG Oncology Cooperative Group, the National Comprehensive Cancer Network, as well as chair multiple U.S. Department of Defense Ovarian Cancer Research Program sections. In recognition of his accomplishments in oncology, he was selected to participate in the American Society of Clinical Oncology (ASCO) Leadership Development Program.
Prior to his current appointment, Dr. Rocconi served as both the director of biobank for molecular, genetic and immunologic studies and the deputy associate director for clinical research at USA Health Mitchell Cancer Institute.
Dr. Rocconi received his medical degree from the University of Alabama at Birmingham in Birmingham, AL. He also completed his residency training in obstetrics and gynecology and a gynecologic oncology fellowship at the University of Alabama at Birmingham.